Nexentis Technologies Inc. develops and operates an AI and data-driven computational biotech platform. The company is headquartered in Hod HaSharon, Israel.
| Revenue (TTM) | 209,000 |
| Gross Profit (TTM) | 135,000 |
| EBITDA | $-6.99M |
| Operating Margin | 0.00% |
| Return on Equity | -119.60% |
| Return on Assets | -37.60% |
| Revenue/Share (TTM) | $0.36 |
| Book Value | $40.42 |
| Price-to-Book | 0.25 |
| Price-to-Sales (TTM) | 4.32 |
| EV/Revenue | 4.18 |
| EV/EBITDA | 0.28 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -77.80% |
| Shares Outstanding | 730,460 |
| Float | 426,450 |
| % Insiders | 0.00% |
| % Institutions | 15.43% |
Volatility is currently contracting